Ensysce Biosciences Enters Material Definitive Agreement

Ticker: ENSCW · Form: 8-K · Filed: Mar 31, 2025 · CIK: 1716947

Ensysce Biosciences, INC. 8-K Filing Summary
FieldDetail
CompanyEnsysce Biosciences, INC. (ENSCW)
Form Type8-K
Filed DateMar 31, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: material-definitive-agreement, equity-securities, corporate-actions

TL;DR

Ensysce Biosciences just signed a big deal for unregistered equity sales.

AI Summary

On March 30, 2025, Ensysce Biosciences, Inc. entered into a Material Definitive Agreement related to unregistered sales of equity securities. The company, formerly known as Leisure Acquisition Corp. until September 13, 2017, is incorporated in Delaware and headquartered in La Jolla, California.

Why It Matters

This filing indicates a significant transaction involving the company's equity, which could impact its financial structure and shareholder value.

Risk Assessment

Risk Level: medium — Unregistered sales of equity securities can sometimes indicate a need for capital or potential dilution, warranting closer examination.

Key Players & Entities

FAQ

What is the nature of the Material Definitive Agreement entered into by Ensysce Biosciences?

The filing indicates the agreement is related to unregistered sales of equity securities.

When was the earliest event reported in this 8-K filing?

The earliest event reported was on March 30, 2025.

What was Ensysce Biosciences, Inc. formerly known as?

Ensysce Biosciences, Inc. was formerly known as Leisure Acquisition Corp.

In which state is Ensysce Biosciences, Inc. incorporated?

Ensysce Biosciences, Inc. is incorporated in Delaware.

What is the principal executive office address for Ensysce Biosciences, Inc.?

The principal executive office is located at 7946 Ivanhoe Avenue, Suite 201, La Jolla, California 92037.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 31, 2025 regarding Ensysce Biosciences, Inc. (ENSCW).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing